$1.57 $0.05 (3.3%)

04:00 PM EST on 12/10/19

Curis Inc Com (NASDAQ:CRIS)

CAPS Rating: 1 out of 5

A drug discovery and development company that is seeking to leverage its innovative biological signaling pathway drug technologies to create new medicines primarily in the field of cancer.

Current Price $1.57 Mkt Cap $50.5M
Open $1.53 P/E Ratio 0.00
Prev. Close $1.52 Div. (Yield) $0.00 (0.0%)
Daily Range $1.46 - $1.60 Volume 790,022
52-Wk Range $0.68 - $2.90 Avg. Daily Vol. 309,111

Caps

How do you think NASDAQ:CRIS will perform against the market?

Add Stock to CAPS Watchlist

All Players

167 Outperform
17 Underperform
 

All-Star Players

13 Outperform
10 Underperform
 

Wall Street

2 Outperform
0 Underperform
 

Top NASDAQ:CRIS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

waderjw (77.85)
Submitted July 14, 2011

They're having good trial runs on their cancer drugs.

louisfool (91.33)
Submitted October 28, 2011

Will underperform until approved. Look for a big pop once that happens.

NASDAQ:CRIS VS S&P 500 (SPY)

Fools bullish on NASDAQ:CRIS are also bullish on:

Fools bearish on NASDAQ:CRIS are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CRIS.

Recs

0
Member Avatar jed71 (99.87) Submitted: 12/4/2019 10:16:18 AM : Underperform Start Price: $1.63 NASDAQ:CRIS Score: +4.55

This company has been around for 20 some odd years, and is NOT friendly to shareholders. Multiple reverse splits. Took forever before they began generating revenue, but even now, they struggle to generate a positive gross margin. Massive losses each quarter and have built up a $1 BILLION accumulated deficit. I have gotten lucky up-thumbing this in the past but it really only deserves a down thumb. Don't waste your hard earned money on this stub. I wouldn't consider shorting this in real life, mostly because bio-techs are so volatile and unpredictable.

Recs

0
Member Avatar SubPrime (< 20) Submitted: 7/29/2014 3:34:54 PM : Outperform Start Price: $9.15 NASDAQ:CRIS Score: -141.72

Looking for bump from earnings.

Recs

0
Member Avatar rknapton (77.74) Submitted: 8/6/2013 7:30:28 PM : Underperform Start Price: $20.50 NASDAQ:CRIS Score: +177.58

Short. Biotech. Revenues have dried up. Issuing lots of stock and raising debt. Big losses.

Leaderboard

Find the members with the highest scoring picks in CRIS.

Score Leader

Broken196

Broken196 (< 20) Score: +298.99

The Score Leader is the player with the highest score across all their picks in CRIS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Broken196 < 20 9/4/2009 Underperform 1Y $11.85 -86.75% +212.24% +298.99 0 Comment
Marshal82 72.04 9/16/2009 Underperform 3Y $11.65 -86.52% +193.98% +280.50 0 Comment
longtermgrowth09 < 20 12/17/2009 Underperform 5Y $14.45 -89.13% +183.07% +272.20 0 Comment
shorttest4 32.70 3/8/2010 Underperform 5Y $15.90 -90.13% +174.30% +264.42 0 Comment
stockjock11 20.88 6/17/2010 Underperform 5Y $8.95 -82.46% +179.13% +261.59 0 Comment
louisfool 91.33 10/28/2011 Underperform 5Y $18.60 -91.56% +143.90% +235.46 2 Comments
boardwalken65 31.44 7/7/2011 Underperform 3M $18.25 -91.40% +131.88% +223.28 0 Comment
EclecticRecluse 80.05 5/4/2011 Underperform 3W $18.60 -91.56% +131.01% +222.57 1 Comment
rknapton 77.74 8/7/2013 Underperform 5Y $20.50 -92.34% +85.24% +177.58 1 Comment
Moondoggie 98.76 10/1/2014 Underperform 5Y $7.05 -77.73% +59.33% +137.06 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CRIS.